Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
5
×
national blog main
national top stories
seattle blog main
5
×
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
praluent
vc
alzheimer's
amgen
biogen
circulation
deals
donald trump
fda
gene therapy
merck
novartis
pbm
What
healthcare
5
×
bio
roundup
moves
acquisition
amazon’s
america
american
based
becker
best
billions
biogen
ceo
cholesterol
circulation
continue
continues
convoluted
crash
debate
democrats
dollars
dreams
drug
drugs
eaton
efficient
emergency
expensive
faces
financial
foe
gene
glimpse
head
headaches
hint
holding
impact
Language
unset
Current search:
healthcare
×
" life sciences "
×
" seattle blog main "
×
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Circulation CEO Talks Sale to LogistiCare & Amazon’s Healthcare Play